Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, ARS Pharmaceuticals Inc’s stock clocked out at $12.31, up 6.76% from its previous closing price of $11.53. In other words, the price has increased by $6.76 from its previous closing price. On the day, 1.52 million shares were traded. SPRY stock price reached its highest trading level at $12.35 during the session, while it also had its lowest trading level at $11.65.
Ratios:
To gain a deeper understanding of SPRY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $30.
On February 10, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $40.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Shawver Laura sold 49,600 shares for $11.21 per share. The transaction valued at 556,046 led to the insider holds 210,346 shares of the business.
Shawver Laura sold 400 shares of SPRY for $4,400 on Mar 05 ’25. The Director now owns 210,346 shares after completing the transaction at $11.00 per share. On Mar 05 ’25, another insider, Shawver Laura, who serves as the Director of the company, bought 50,000 shares for $11.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1196353536 and an Enterprise Value of 991639168. For the stock, the TTM Price-to-Sale (P/S) ratio is 465.51 while its Price-to-Book (P/B) ratio in mrq is 5.95. Its current Enterprise Value per Revenue stands at 386.152 whereas that against EBITDA is -16.406.
Stock Price History:
The Beta on a monthly basis for SPRY is 0.90, which has changed by 0.36777782 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $7.55. The 50-Day Moving Average of the stock is 3.90%, while the 200-Day Moving Average is calculated to be 1.16%.
Shares Statistics:
It appears that SPRY traded 1.36M shares on average per day over the past three months and 1382680 shares per day over the past ten days. A total of 97.15M shares are outstanding, with a floating share count of 51.30M. Insiders hold about 47.22% of the company’s shares, while institutions hold 50.58% stake in the company. Shares short for SPRY as of 1740700800 were 19003671 with a Short Ratio of 13.97, compared to 1738281600 on 14670470. Therefore, it implies a Short% of Shares Outstanding of 19003671 and a Short% of Float of 36.76.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
